ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,209,952 | -52.1% | 791,200 | -45.8% | 0.04% | -53.4% |
Q2 2023 | $29,694,549 | -18.8% | 1,459,909 | -13.2% | 0.09% | -22.1% |
Q1 2023 | $36,581,759 | -44.4% | 1,681,147 | -20.9% | 0.11% | -49.6% |
Q4 2022 | $65,828,958 | +2.2% | 2,124,200 | -15.9% | 0.22% | -12.8% |
Q3 2022 | $64,443,000 | +272.7% | 2,526,200 | +196.6% | 0.26% | +252.1% |
Q2 2022 | $17,292,000 | -47.0% | 851,800 | -35.4% | 0.07% | -43.4% |
Q1 2022 | $32,597,000 | +264.8% | 1,317,600 | +412.4% | 0.13% | +258.3% |
Q4 2021 | $8,936,000 | -45.3% | 257,145 | -66.2% | 0.04% | -55.0% |
Q4 2020 | $16,346,000 | +247.0% | 760,300 | +260.5% | 0.08% | +158.1% |
Q2 2020 | $4,711,000 | +1019.0% | 210,886 | +714.2% | 0.03% | +1450.0% |
Q4 2019 | $421,000 | -82.8% | 25,900 | -22.9% | 0.00% | -81.8% |
Q1 2019 | $2,454,000 | +23.0% | 33,600 | +68.0% | 0.01% | +37.5% |
Q3 2018 | $1,995,000 | – | 20,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |